| Literature DB >> 32472965 |
Lisanne P W Canjels1,2,3, Walter H Backes1,2,4, Tamar M van Veenendaal1,2, Marielle C G Vlooswijk2,5,6, Paul A M Hofman1, Albert P Aldenkamp2,3,5,6, Rob P W Rouhl2,5,6, Jacobus F A Jansen1,2,3.
Abstract
BACKGROUND ANDEntities:
Keywords: 7T; fMRI; hippocampus; lateralization; volumes
Mesh:
Year: 2020 PMID: 32472965 PMCID: PMC7586826 DOI: 10.1111/jon.12739
Source DB: PubMed Journal: J Neuroimaging ISSN: 1051-2284 Impact factor: 2.486
Patient Characteristics
| EEG Characteristics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patient Number | Location | Lateralization | Age (Years) | Sex | Age of Onset (Years) | Seizure Frequency | Medication Type | Background Pattern | Focal Abnormalities | Epileptiform Discharges |
| 1 | Temporal | Left | 23 | Male | 2 | Seizure‐free | Valproate | Normal | Left temporal slowing | Left temporal abnormalities |
| 2 | Temporal | Left | 45 | Male | 32 | Seizure‐free | Carbamazepine Valproate | Normal | Left anterior temporal slowing | Left temporal abnormalities |
| 3 | Temporal | Left | 31 | Male | 12 | Seizure‐free | Oxcarbazepine | Normal | Left temporal slowing | None |
| 4 | Temporal | Right | 63 | Female | 38 | <12/year | Lamotrigine | Normal | Slight right temporal slowing | Right temporal abnormalities |
| 5 | Frontal | Left | 20 | Female | 4 | <12/year | Lamotrigine | Normal | Light left temporal focal slowing | Left frontal and temporal abnormalities |
| 6 | Frontal | Right | 25 | Male | 23 | <1/year | Carbamazepine | Normal | Right midtemporal slow activity | Right frontocentral abnormalities |
| 7 | Temporal | Unknown | 44 | Female | 1 | <12/year | Levetiracetam | Normal | None | None |
| 8 | Temporal | Unknown | 69 | Male | 26 | Seizure‐free | Carbamazepine | N/A | N/A | N/A |
| 9 | Temporal | Unknown | 45 | Male | 10 | <12/year | Carbamazepine | N/A | N/A | N/A |
| 10 | Temporal | Unknown | 36 | Male | 18 | <1/year | Carbamazepine | Normal | Left and right midtemporal slow activity | None |
N/A, not available.
Fig 1Example of hippocampal segmentation in a healthy subject (male, 25 years). CA, cornu ammonis; DG, dentate gyrus.
Fig 2Example illustrating the symmetric hippocampal region in a healthy subject (male, 25 years, A1, A2, A3) and the left‐sided TLE patient with the largest volumetric lateralization (#3, male, 45 years, B1, B2, B3). Note the atrophy in the patient. R, right; L, Left; LH, left hemisphere; RH, right hemisphere.
Regional Volumes, fALFF, and LI of the Controls
| Hippocampus | Subiculum | CA1 | CA2/3 | CA4 | DG | Temporal Lobe | Frontal Lobe | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Volume (cm3) | Left | 3.00 ± .27 | .41 ± .05 | .59 ± .07 | .18 ± .02 | .24 ± .03 | .29 ± .03 | 15.02 ± 1.50 | 30.70 ± 30.20 | |
| Right | 2.93 ± .29 | .39 ± .04 | .60 ± .08 | .18 ± .02 | .24 ± .03 | .28 ± .03 | 15.07 ± 1.47 | 31.07 ± 2.92 | ||
| Volume LI (×10−2) | Median | 1.4 | 2.8 | −1.0 | −.6 | .3 | .6 | −.3 | −.1 | |
| 95% CI | Lower | .3 | .5 | −1.9 | −3.1 | −.3 | −.3 | −.9 | −1.6 | |
| Upper | 2.0 | 4.3 | .4 | 1.3 | 2.2 | 2.0 | .7 | .3 | ||
| fALFF | Left | 1.18 ± .11 | 1.10 ± .08 | 1.12 ± .10 | 1.04 ± .08 | 1.06 ± .09 | 1.12 ± .08 | 1.27 ± .10 | 1.37 ± .11 | |
| Right | 1.14 ± .09 | 1.13 ± .10 | 1.14 ± .08 | 1.08 ± .09 | 1.08 ± .11 | 1.10 ± .09 | 1.27 ± .09 | 1.36 ± .10 | ||
| Fluctuation amplitude LI (×10−2) | Median | 2.4 | −2.1 | −.2 | −1.5 | −2.2 | 1.4 | −.08 | .2 | |
| 95% CI | Lower | −.01 | −3.0 | −2.3 | −4.2 | −2.8 | −.7 | −.4 | −.4 | |
| Upper | 3.7 | .6 | .9 | .4 | 1.7 | 2.8 | 1.2 | .7 |
Significantly different from zero. Data represent mean ± standard deviation unless otherwise indicated.
CA, cornu ammonis; CI, confidence interval; DG, dentate gyrus; fALFF, fractional amplitude of low frequency fluctuations; LI, lateralization index.
The Volumetric LI in the Epilepsy Group
| LI (×10−2) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Focal Epilepsy | Location | Patient Number | Hippocampus | Subiculum | CA1 | CA2/3 | CA4 | DG | Temporal Lobe | Frontal Lobe |
| Temporal | Left | 1 | −1.9 | −2.2 | −3.3 | −6.1 | −5.3 | −4.8 | −1.1 | −.7 |
| 2 | −2.4 | −1.2 | −1.8 | −5.4 | −4.3 | −3.2 | .4 | −.4 | ||
| 3 | −2.2 | −2.2 | −7.6 | −11.1 | −4.2 | −6.1 | .08 | −2.5 | ||
| Right | 4 | 2.8 | .4 | 1.7 = | 4.0 | .3 | .9 | −.4 | −.9 | |
| Frontal | Left | 5 | −.5 | 2.9 | −.9 | −1.9 | −1.0 | −.5* | −1.3 | .8 |
| Right | 6 | 1.9 | 3.5 | 3.6 | .5 | 1.7 | 2.3 | 1.0 | .9 | |
| Temporal | Unknown | 7 | −.9 | .3 | −3.3 | −.06 | 1.1 | .5 | −.8 | −1.5 |
| 8 | −2.1 | .8 | −1.9 | −2.4 | −3.4 | −3.4 | −.03 | −1.1 | ||
| 9 | 2.2 | 5.5 | 2.6 | 2.4 | −1.2 | .003 | 2.6 | −.02 | ||
| 10 | 2.1 | 1.4 | −2.4 | .8 | 1.6 | 3.0 | −2.1 | .4 | ||
LI metrics located outside the 95% CI of those of controls.
CA, cornu ammonis; CI, confidence interval; DG, dentate gyrus; LI, lateralization index.
Fig 3Example of the fALFF maps in a healthy subject (male, 25 years, A1, A2, A3) and a left‐sided TLE patient (#3) (male, 45 years, B1, B2, B3). The hippocampi are delineated with a blue contour. Brighter spots indicate higher activity. R, right; LH, left hemisphere; RH, right hemisphere.
The Fluctuation Amplitude LI in the Epilepsy Group
| LI (×10−2) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Focal Epilepsy | Location | Patient Number | Hippocampus | Subiculum | CA1 | CA2/3 | CA4 | DG | Temporal Lobe | Frontal Lobe |
| Temporal | Left | 1 | 5.3 | 6.9 | 5.4 | .9 | 3.6 | 6.9 | −1.6 | .2 |
| 3 | 7.5 | 3.7 | 1.4 | 4.6 | −1.3 | 4.2 | 2.8 | −.2 | ||
| Right | 4 | 6.6 | −1.3 | 3.8 | 1.9 | −1.9 | −.9 | −.03 | −1.9 | |
| Frontal | Left | 5 | 4.7 | .6 | 6.3 | 3.3 | −.8 | 2.7 | −1.6 | .04 |
| Temporal | Unknown | 7 | −1.6 | .8 | −3.2 | 3.9 | −1.9 | 2.0 | .9 | −.1 |
| 8 | .2 | −9.5 | −1.0 | 5.3 | 4.0 | 1.7 | −2.2 | −1.1 | ||
| 9 | 4.8 | 10.6 | −4.3 | .3 | −.8 | −1.6 | −3.0 | −.5 | ||
| 10 | 2.3 | −6.0 | −2.0 | −1.4 | 8.8 | 8.2 | −1.9 | −.05 | ||
LI metrics located outside the 95% CI of those of controls.
CA, cornu ammonis; CI, confidence interval; DG, dentate gyrus; LI, lateralization index.